Objective:

This hybrid conference will bring legal practitioners working with the pharmaceutical sector up-to-date on the latest regulatory developments, legislative initiatives and case law.

Key topics:

• Key priorities of the new European Commission
• The European Health Union
• The European Health Data Space
• Ongoing revision of the EU Pharma Regulatory legal framework
• Towards a Critical Medicines Act
• Biotechnology and the future of research and pharmaceutical innovation
• Artificial intelligence in the life science sector
• Medical devices, in vitro diagnostics and borderline products
• SoHo
• Pricing and HTA
• EMA recent activities  

Who should attend?

In-house counsel, lawyers in private practice, lawyers in national ministries and authorities dealing with regulation of the sector.

Online participation option:

The event will be streamed live online.

You have the option to follow the conference on Zoom, enabling you to ask questions and take part in the discussion with participants in Brussels.